Plant Immunity May Benefit Human Medicine
Ephraim Philip Lansky*, Eviatar NevoInstitute of Evolution, Haifa University, Haifa, Israel
Abstract
Brachypodium distachyon, a model genomic organism, has also been studied metabolomically for its reactions to specific stimuli such as fungal infection or proximity to other botanical organisms. Coincidentally, the metabolic output in response to pathogenic fungi produces compounds (phospholipids) valuable in treating invasive fungal infections in humans. This leads to general hypothesis that specific stressing of plants may produce compounds of value for the treatment resulting from homologous or identical stressors, and so constitute a novel putative approach for pharmaceutical discovery and development. Some specific examples and suggestions for future study are considered
Article Information
Article History:
Received Date: 16/1/2009
Revision Received Date: 9/2/2009
Acceptance Date: 24/2/2009
Electronic publication date: 14/04/2009
Collection year: 2009
© William F. Wade; Licensee Bentham Open.
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (
http: //creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
* Address correspondence to this author at the Institute of Evolution, Haifa University, Haifa, Israel; Tel: +972 545 273 156; E-mail: elansky@research.haifa.ac.il
Open Peer Review Details |
Manuscript submitted on 16-1-2009 |
Original Manuscript |
Plant Immunity May Benefit Human Medicine |